From the Department of Radiology (S.B.T.v.R.), Noordwest Ziekenhuisgroep, Alkmaar, the Netherlands
Department of Radiology (J.P.P., M.S., H.G.K., W.J.v.R.), Elisabeth-Tweesteden Ziekenhuis, Tilburg, the Netherlands.
AJNR Am J Neuroradiol. 2018 May;39(5):859-863. doi: 10.3174/ajnr.A5608. Epub 2018 Mar 22.
The Woven EndoBridge (WEB) is an intrasaccular flow diverter intended to treat wide-neck aneurysms. The latest generation WEBs needed a 0.021-inch microcatheter in the small sizes. Recently, a lower profile range of WEBs compliant with a 0.017-inch microcatheter (WEB 17) has been introduced. We present the first clinical results of treatment of both ruptured and unruptured aneurysms with the WEB 17.
Between December 2016 and September 2017, forty-six aneurysms in 40 patients were treated with the WEB 17. No supporting stents or balloons were used. Twenty-five aneurysms were ruptured (54%). There were 6 men and 34 women (mean age, 62 years; median, 63 years; range, 46-87 years). The mean aneurysm size was 4.9 mm (median, 5 mm; range, 2-7 mm).
There were 2 thromboembolic procedural complications without clinical sequelae and no ruptures. The overall permanent procedural complication rate was 0% (0 of 40; 97.5% CI, 0%-10.4%). Imaging follow-up at 3 months was available in 33 patients with 39 aneurysms (97.5% of 40 eligible aneurysms). In 1 aneurysm, the detached WEB was undersized and the remnant was additionally treated with coils after 1 week. This same aneurysm reopened at 3 months and was again treated with a second WEB. One other aneurysm showed persistent WEB filling at 3 months. Complete occlusion was achieved in 28 of 39 aneurysms (72%), and 9 aneurysms (23%) showed a neck remnant.
The WEB 17 is safe and effective for both ruptured and unruptured aneurysms. The WEB 17 is a valuable addition to the existing WEB size range, especially for very small aneurysms.
Woven EndoBridge(WEB)是一种腔内血流分流器,旨在治疗宽颈动脉瘤。最新一代的 WEB 需要在小尺寸时使用 0.021 英寸微导管。最近,推出了一种符合 0.017 英寸微导管(WEB 17)的更低轮廓范围的 WEB。我们介绍了使用 WEB 17 治疗破裂和未破裂动脉瘤的首批临床结果。
2016 年 12 月至 2017 年 9 月,40 名患者的 46 个动脉瘤接受了 WEB 17 的治疗。未使用支撑支架或球囊。25 个动脉瘤破裂(54%)。其中 6 名男性和 34 名女性(平均年龄 62 岁;中位数 63 岁;范围 46-87 岁)。平均动脉瘤大小为 4.9 毫米(中位数 5 毫米;范围 2-7 毫米)。
有 2 例血栓栓塞性手术并发症,无临床后遗症,无破裂。总的永久性手术并发症发生率为 0%(40 例中 0 例;97.5%CI,0%-10.4%)。33 名患者的 39 个动脉瘤(40 个符合条件的动脉瘤中的 97.5%)可获得 3 个月的影像学随访。在 1 个动脉瘤中,分离的 WEB 尺寸不足,残留部分在 1 周后用线圈进行了额外治疗。同一动脉瘤在 3 个月时再次开放,再次用第二个 WEB 治疗。另一个动脉瘤在 3 个月时仍有 WEB 充盈。28 个动脉瘤(72%)达到完全闭塞,9 个动脉瘤(23%)有颈部残留。
WEB 17 对于破裂和未破裂的动脉瘤都是安全有效的。WEB 17 是现有 WEB 尺寸范围的有价值补充,特别是对于非常小的动脉瘤。